Author

Khloud A. Elsharawy

Observed names: Khloud A El-Sharawy, Khloud A ElSharawy, Khloud A Elsharawy, Khloud A. El-sharawy, Khloud Elsharawy

Institutions: Damietta University, University of Nottingham

Observed institutions: Damietta University, University of Nottingham, Nottingham City Hospital

ORCID: 0000-0003-2114-8138

Observed ORCID: 0000-0003-2114-8138

OpenAlex ID: A5063890475

The nucleolar-related protein Dyskerin pseudouridine synthase 1 (DKC1) predicts poor prognosis in breast cancer

2020 · Khloud A. Elsharawy, Omar J. Mohammed, et al. · British Journal of Cancer · 62

Artificial intelligence grading of breast cancer: a promising method to refine prognostic classification for management precision

2021 · Khloud A Elsharawy, Thomas A Gerds, et al. · Histopathology · 41

Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer

2022 · Yousif Kariri, Michael S. Toss, et al. · Breast Cancer Research and Treatment · 39

Upregulation of Cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion.

2022 · Abrar I Aljohani, Michael S Toss, et al. · PubMed · 32

Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study

2020 · Emad A Rakha, Mansour Alsaleem, et al. · Histopathology · 28

Chitosan coating does not prevent the effect of the transfer of green silver nanoparticles biosynthesized by Streptomyces malachitus into fetuses via the placenta

2020 · Khloud Elsharawy, Mohamed Abou-Dobara, et al. · Reproductive Biology · 27

Prognostic significance of nucleolar assessment in invasive breast cancer

2019 · Khloud A Elsharawy, Michael S Toss, et al. · Histopathology · 22

Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer

2021 · Maryam Althobiti, Khloud A. El-sharawy, et al. · Breast Cancer Research and Treatment · 20

Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer

2020 · Khloud A. Elsharawy, Maryam Althobiti, et al. · Breast Cancer Research and Treatment · 20

Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer

2022 · Yousif A. Kariri, Chitra Joseph, et al. · Cancers · 12

Works count: 10

Citation count: 303

H-index: 10

I10-index: 10